EUVIMEDEUVIMED entdecken
Crossref

Enantioselective Effect of Chiral Small Molecules in SARS‐CoV‐2 Vaccine‐Induced Immune Response

Zhengmiao Zhou, Yufang Zhang, Honghan Ji, Yu Jin, Sisi Chen, Pengfei Duan iD, Ye Liu

Angewandte Chemie International Edition · 2023

DOI: 10.1002/anie.202301085 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2023. Verfasst von Zhengmiao Zhou und 6 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, Yunnan, 650000, China. Hauptthemen laut MEDLINE: COVID-19 Vaccines, COVID-19. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Ministry of Science and Technology of the People's Republic of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although numerous chiral small molecules have been discovered and synthesized, the investigation on their enantioselective immunological effects remains limited. In this study, we designed and synthesized a pair of small molecule enantiomers ( R / S ‐ResP) by covalently bonding two immunostimulators (resiquimod/Res) onto a planar chiral framework (paracyclophane/P). Notably, we found that S ‐ResP exhibits a 4.05‐fold higher affinity for toll‐like receptor 7 (TLR7) than R ‐ResP, thereby more effectively enhancing the functions of dendritic cells and macrophages in cytokine secretion and antigen internalization. Furthermore, we observed that S ‐ResP significantly enhances RBD antigen‐induced cross‐neutralization against various SARS‐CoV‐2 strains compared to R ‐ResP. These findings demonstrate the enantioselective effects of small molecules on regulating vaccine‐induced immune responses and emphasize the significance of chirality in designing small molecular adjuvants.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19 VaccinesCOVID-19HumansStereoisomerismSARS-CoV-2Adjuvants, ImmunologicImmunityAntibodies, ViralAntibodies, Neutralizing

Stichwörter der Autor:innen

AdjuvantChiralityImmunologySARS-CoV-2 VaccineSmall Molecule

Substanzen

COVID-19 VaccinesAdjuvants, ImmunologicAntibodies, ViralAntibodies, Neutralizing

Autor:innen und Institutionen

  • Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Kunming, Yunnan, 650000, China.
  • CAS Key Laboratory of Nanosystem and Hierarchical Fabrication, National Center for Nanoscience and Technology (NCNST), No.11, ZhongGuanCun BeiYiTiao, Beijing, 100190, P. R. China.

ORCID-Profile: Pengfei Duan

Förderung

  • National Natural Science Foundation of China
  • Ministry of Science and Technology of the People's Republic of China

Zitieren

APA

Zhou, Z., Zhang, Y., Ji, H., Jin, Y., Chen, S., Duan, P., & Liu, Y. (2023). Enantioselective Effect of Chiral Small Molecules in SARS‐CoV‐2 Vaccine‐Induced Immune Response. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202301085

Vancouver

Zhou Z, Zhang Y, Ji H, Jin Y, Chen S, Duan P, et al. Enantioselective Effect of Chiral Small Molecules in SARS‐CoV‐2 Vaccine‐Induced Immune Response. Angewandte Chemie International Edition. 2023. doi:10.1002/anie.202301085

BibTeX
@article{Zhou2023,
  author = {Zhou, Zhengmiao and Zhang, Yufang and Ji, Honghan and Jin, Yu and Chen, Sisi and Duan, Pengfei and Liu, Ye},
  title = {Enantioselective Effect of Chiral Small Molecules in SARS‐CoV‐2 Vaccine‐Induced Immune Response},
  journal = {Angewandte Chemie International Edition},
  year = {2023},
  doi = {10.1002/anie.202301085}
}
Kostenlos starten →